GSA Capital Partners »

Relmada Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $480k 103k 4.65
2023-12-31 $764k 185k 4.14
2023-09-30 $586k 195k 3.00
2023-06-30 $668k 272k 2.46
2023-03-31 $141k 63k 2.25
2022-12-31 $428k 123k 3.49
2021-12-31 $393k 17k 22.55